Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

glomerulonephritis/triglyceride

Веза се чува у привремену меморију
Страна 1 од 84 резултати

Treatment of experimental immune complex glomerulonephritis by sodium alginate.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
We have studied the therapeutic efficacy of the sodium alginate in experimental immune complex glomerulonephritis. Bovine serum albumin (BSA) nephritis was induced in rats by a subcutaneous immunization and daily intravenous administration of BSA. Sodium alginate at two different doses (25 and 50

[Clinical observation on effect of shenle capsule in treating mesangial proliferating glomerulonephritis].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE To study the therapeutic effect of Shenle capsule (SLC) in treating mesangial proliferating glomerulonephritis (MsPGN) and to explore its therapeutic mechanism and clinical indication. METHODS Adopting case control method, taking angiotensin-converting enzyme inhibitor (benazepril) as

Proteinuria and plasma hexosugars in early-stage glomerulonephritis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Marked changes in the plasma concentration of several non-glucose monosaccharides have been detected among patients++ with end-stage renal disease. To find changes specific to renal disease and not caused by a failing urinary excretion, we studied the plasma monosaccharide concentration in patients

[Relationship between renal biopsy histopathology and profile of changes in serum protein, lipids and proteinuria in patients with nephrotic syndrome due to chronic glomerulonephritis].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Relationship was assessed between the type of renal pathology and the degree of plasma protein and lipid abnormalities in 59 patients with nephrotic syndrome due to chronic glomerulonephritis (GN). All patients were divided into 5 subgroups according to the type of renal pathology (extracapillary

[The concentration of adenine nucleotides in platelets of patients with primary chronic glomerulonephritis].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Nephrotic syndrome (n.s.) is associated with numerous blood coagulation abnormalities and a marked predisposition to thromboembolism. Increased aggregation and activation of platelets in patients with glomerulonephritis (g.l.n. p.t.s.) may partly explain this status. The aim of this study was to

[Evaluation of platelet membrane structure in patients with chronic glomerulonephritis (CGN)].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The structure of platelet membrane determines platelet surface glycoprotein receptors and correct cell function. Meanwhile different diseases and drugs may induce changes in this structure. The aim of this study was to determine structure of platelet lipid bilayer in patients with chronic

Metabolic syndrome in IgA glomerulonephritis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE Metabolic syndrome (MetS) may have an independent impact on the development of chronic kidney disease. This study examines the prevalence of MetS in subjects with IgA glomerulonephritis (IgAGN) and its impact on disease progression in a retrospective fashion. METHODS Altogether, 174

[Effect of treating glomerulonephritis with omega 3 fatty acids for selected parameters of hemostasis, blood platelet function and lipid metabolism].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Disturbances in serum lipids, hemostasis and platelet functions are frequent features in some kidney diseases and may contribute to the progression of atherosclerosis with its complications. Recently, an attention has been paid on beneficial effects of fish oil on serum lipids and hemostasis, and

Adiponectin is increased and correlated with the degree of proteinuria, but plasma leptin is not changed in patients with chronic glomerulonephritis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE Altered regulation of adiponectin and leptin may be relevant to endothelial dysfunction and cardiovascular complications in patients with chronic glomerulonephritis. METHODS The relationship between the levels of plasma adiponectin, leptin and proteinuria, glomerular filtration rate and

Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND We previously reported urinary podocytes to be a marker of glomerular injury. The aim of the present study was to determine whether cerivastatin, a newly developed, potent synthetic statin, affects proteinuria and urinary podocyte excretion in patients with chronic glomerulonephritis

[Plasma lipids in patients with chronic glomerulonephritis].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The author examined 78 patients with chronic glomerulonephritis and verified their diagnosis on the basis of the kidney biopsy data. With regard to the severity of the tubular interstitial component the patients were enrolled in three groups. It was stated that with the increasing changes developed

[Effects of simvastatin therapy on the lipid blood spectrum and nitric oxide in patients with chronic glomerulonephritis].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The authors have evaluated the effects of Simvastatin on the lipid blood spectrum and nitric oxide in patients with chronic glomerulonephritis (CGN). 100 patients with different types of glomerular disease were divided in two groups depending on the treatment scheme: Group B received the traditional

Expression and clinical significance of thrombospondin-1 and plasminogen activator inhibitor-1 in patients with mesangial proliferative glomerulonephritis

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Background: As a common pathological type of glomerular disease in China, mesangial proliferative glomerulonephritis is related to plasminogen activator inhibitor-1 (PAI-1) and thrombospondin-1 (TSP-1). Here, this study aims to

[Tests for cell membrane destabilization in assessing activity-progression of chronic glomerulonephritis].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE To study the role of cell membrane destabilization (MD) in the serum and urine in assessing activity/progression of primary chronic glomerulonephritis (CGN). METHODS The trial entered 163 patients (mean age 38 +/- 7.3 years) with primary CGN in active phase, 64 patients with CGN in

Novel therapeutic approach by culture filtrate of Cryptococcus neoformans var. gattii (CneF) in experimental immune complex glomerulonephritis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The present study was undertaken to determine the therapeutic effect of the culture filtrate of Cryptococcus neoformans var. gattii (CneF) in experimental immune complex glomerulonephritis. Bovine serum albumin (BSA) nephritis was induced in rats by a subcutaneous immunization and daily intravenous
Придружите се нашој
facebook страници

Најкомплетнија база лековитог биља подржана науком

  • Ради на 55 језика
  • Биљни лекови потпомогнути науком
  • Препознавање биљака по слици
  • Интерактивна ГПС мапа - означите биље на локацији (ускоро)
  • Читајте научне публикације повезане са вашом претрагом
  • Претражите лековито биље по њиховим ефектима
  • Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима

Google Play badgeApp Store badge